Elderly individuals, especially those with pre-existing conditions like type 2 diabetes mellitus (T2DM), have a high risk for developing severe cases of COVID-19. The aim of this work was to characterize the alterations of blood immune cells (BIC) in patients with symptomatic COVID-19 and confirmed SARS-CoV-2 infection, ≥60 years and who needed hospitalization in the Centro de Salud Hospital of Tucuman, Argentina, during the second peak of the pandemic in Argentina. Ten patients were enrolled from December 2020 to May 2021. Blood samples were taken at the time of admission (day 0) and five days after (day 5) for routine laboratory tests and the characterization of BIC by flow cytometry. Most of the patients were men (70%) aged between 60 and 78 years. The 70% of patients had T2DM while 50% had arterial hypertension. At day 0, all the patients had increased neutrophils and inflammatory markers (C reactive protein and D-dimers) and reduced numbers of lymphocytes, HLA-DRhi monocytes, CD16+CD56+ NK cells, CD3+HLA−DR+CD25+ cells, CD4+ and CD8+ T cells in blood. Patients received a standard treatment for COVID-19 care (O2, corticosteroids and antibiotics). The hospital treatment normalized the levels of BIC (day 5) in 30% of patients who were those with no comorbidities. In patients with T2DM, BIC recovery was variable. In T2DM patients who required administration of plasma (30%), prolonged O2 therapy (40%) or referral to the intensive care unit (10%) significant reductions of CD16+CD56+, CD3+HLA−DR+CD25+, CD4+ and CD8+ cells were observed between days 0 and 5. In line with previous studies, our results show that absolute counts of major lymphocyte subsets in blood are significantly and substantially decreased during the course of severe COVID-19 disease in elderly patients. These BIC alterations may persist despite clinical care in elderly patients with T2DM. Further studies are needed to investigate the utility of early lymphocyte subset measurements as prognostic biomarkers of disease severity, mortality, and response to treatment in COVID-19 elderly patients with T2DM.
References
[1]
Pearson-Stuttard, J., Blundell, S., Harris, T., Cook, D.G. and Critchley, J. (2016) Diabetes and Infection: Assessing the Association with Glycaemic Control in Population-Based Studies. The Lancet Diabetes & Endocrinology, 4, 148-158.
https://doi.org/10.1016/S2213-8587(15)00379-4
[2]
Rao Kondapally Seshasai, S., Kaptoge, S., Thompson, A., Di Angelantonio, E., Gao, P., Sarwar, N., Whincup, P.H., Mukamal, K.J., Gillum, R.F., Holme, I., Njolstad, I., Fletcher, A., Nilsson, P., Lewington, S., Collins, R., Gudnason, V., Thompson, S.G., Sattar, N., Selvin, E., Hu, F.B. and Danesh, J. (2011) Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death. The New England Journal of Medicine, 364, 829-841. https://doi.org/10.1056/NEJMoa1008862
[3]
Carey, I.M., Critchley, J.A., Dewilde, S., Harris, T., Hosking, F.J. and Cook, D.G. (2018) Risk of Infection in Type 1 and Type 2 Diabetes Compared with the General Population: A Matched Cohort Study. Diabetes Care, 41, 513-521.
https://doi.org/10.2337/dc17-2131
[4]
McDonald, H.I., Nitsch, D., Millett, E.R.C., Sinclair, A. and Thomas, S.L. (2014) New Estimates of the Burden of Acute Community-Acquired Infections among Older People with Diabetes Mellitus: A Retrospective Cohort Study Using Linked Electronic Health Records. Diabetic Medicine, 31, 606-614.
https://doi.org/10.1111/dme.12384
[5]
Peleg, A.Y., Weerarathna, T., McCarthy, J.S. and Davis, T.M.E. (2007) Common Infections in Diabetes: Pathogenesis, Management and Relationship to Glycaemic Control. Diabetes Metabolism Research and Reviews, 23, 3-13.
https://doi.org/10.1002/dmrr.682
[6]
Yang, J.K., Feng, Y., Yuan, M.Y., Yuan, S.Y., Fu, H.J., Wu, B.Y., Sun, G.Z., Yang, G.R., Zhang, X.L., Wang, L., Xu X., Xu, X.P. and Chan, J.C.N. (2006) Plasma Glucose Levels and Diabetes Are Independent Predictors for Mortality and Morbidity in Patients with SARS. Diabetic Medicine, 23, 623-628.
https://doi.org/10.1111/j.1464-5491.2006.01861.x
[7]
Banik, G.R., Alqahtani, A.S., Booy, R. and Rashid, H. (2016) Risk Factors for Severity and Mortality in Patients with MERS-CoV: Analysis of Publicly Available Data from Saudi Arabia. Virologica Sinica, 31, 81-84.
https://doi.org/10.1007/s12250-015-3679-z
[8]
Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., Zhao, L., Fan, H., Luo, S. and Hu, D. (2020) Diabetes Is a Risk Factor for the Progression and Prognosis of COVID-19. Diabetes Metabolism Research and Reviews, 36, e3319. https://doi.org/10.1002/dmrr.3319
[9]
Zhu, L., She, Z.G., Cheng, X., Qin, J.J., Zhang, X.J., Cai, J., Lei, F., Wang, H., Xie, J., et al. (2020) Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-Existing Type 2 Diabetes. Cell Metabolism, 31, 1068-1077.e3.
https://doi.org/10.1016/j.cmet.2020.04.021
[10]
Roberts, J., Pritchard, A.L., Treweeke, A.T., Rossi, A.G., Brace, N., Cahill, P., MacRury, S.M., Wei, J. and Megson, I.L. (2021) Why Is COVID-19 More Severe in Patients with Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System. Frontiers in Cardiovascular Medicine, 7, Article ID: 629933. https://doi.org/10.3389/fcvm.2020.629933
[11]
Wang, J., Li, Q., Yin, Y., Zhang, Y., Cao, Y., Lin, X., Huang, L., Hoffmann, D., Lu, M. and Qiu, Y. (2020) Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19. Frontiers in Immunology, 11, Article ID: 2063.
https://doi.org/10.3389/fimmu.2020.02063
[12]
Shi, H., Wang, W., Yin, J., Ouyang, Y., Pang, L., Feng, Y., Qiao, L., Guo, X., Shi, H., Jin, R. and Chen, D. (2020) The Inhibition of IL-2/IL-2R Gives Rise to CD8+ T Cell and Lymphocyte Decrease through JAK1-STAT5 in Critical Patients with COVID-19 Pneumonia. Cell Death & Disease, 11, Article ID: 429.
https://doi.org/10.1038/s41419-020-2636-4
[13]
Sun, Y., Dong, Y., Wang, L., Xie, H., Li, B., Chang, C. and Wang, F.S. (2020) Characteristics and Prognostic Factors of Disease Severity in Patients with COVID-19: The Beijing Experience. Journal of Autoimmunity, 112, Article ID: 102473.
https://doi.org/10.1016/j.jaut.2020.102473
[14]
Gan, J., Li, J., Li, S. and Yang, C. (2020) Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients with COVID-19 Pneumonia: A Retrospective Case-Control Study. Frontiers in Public Health, 8, Article ID: 299.
https://doi.org/10.3389/fpubh.2020.00299
[15]
Urra, J.M., Cabrera, C.M., Porras, L. and Ródenas, I. (2020) Selective CD8 Cell Reduction by SARS-CoV-2 Is Associated with a Worse Prognosis and Systemic Inflammation in COVID-19 Patients. Clinical Immunology, 217, Article ID: 108486.
https://doi.org/10.1016/j.clim.2020.108486
[16]
Huang, W., Berube, J., McNamara, M., Saksena, S., Hartman, M., Arshad, T., Bornheimer, S.J. and O’Gorman, M. (2020) Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis. Cytometry A, 97, 772-776.
https://doi.org/10.1002/cyto.a.24172
[17]
Iannetta, M., Buccisano, F., Fraboni, D., Malagnino, V., Campogiani, L., Teti, E., Spalliera, I., Rossi, B., Di Lorenzo, A., Palmieri, R., Crea, A., Zordan, M., Vitale, P., Voso, M.T. andreoni, M. and Sarmati, L. (2021) Baseline T-Lymphocyte Subset Absolute Counts Can Predict Both Outcome and Severity in SARS-CoV-2 Infected Patients: A Single Center Study. Scientific Reports, 11, Article No. 12762.
https://doi.org/10.1038/s41598-021-90983-0
[18]
Faivre, V., Lukaszewicz, A.C. and Payen, D. (2016) Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells. PLOS ONE, 11, e0164489. https://doi.org/10.1371/journal.pone.0164489
[19]
Tamulyte, S., Kopplin, J., Brenner, T., Weigand, M.A. and Uhle, F. (2019) Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients with Complicated Courses—A Proof-of-Principle Study. Frontiers in Immunology, 10, Article No. 432.
https://doi.org/10.3389/fimmu.2019.00432
[20]
Cheadle, W.G., Hershman, M.J., Wellhausen, S.R. and Polk, H.C. (1991) HLA-DR Antigen Expression on Peripheral Blood Monocytes Correlates with Surgical Infection. The American Journal of Surgery, 161, 639-645.
https://doi.org/10.1016/0002-9610(91)91247-G
[21]
Yang, H.M., Yu, Y., Chai, J.K., Hu, S., Sheng, Z.Y. and Yao, Y.M. (2008) Low HLA-DR Expression on CD14+ Monocytes of Burn Victims with Sepsis, and the Effect of Carbachol in Vitro. Burns, 34, 1158-1162.
https://doi.org/10.1016/j.burns.2008.01.026
[22]
Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini, S. (2008) Functions of Natural Killer Cells. Nature in Immunology, 9, 503-510.
https://doi.org/10.1038/ni1582
[23]
Kalpakci, Y., Hacibekiroglu, T., Trak, G., Karacaer, C., Demirci, T., Kocayigit, H., Sunu, C., Varim, C. and Falay, M. (2020) Comparative Evaluation of Memory T Cells in COVID-19 Patients and the Predictive Role of CD4+CD8+ Double Positive T Lymphocytes as a New Marker. Revista da Associacao Médica Brasileira, 66, 1666-1672. https://doi.org/10.1590/1806-9282.66.12.1666
[24]
Han, M., Ma, K., Wang, X., Yan, W., Wang, H., You, J., Wang, Q., Chen, H., Guo, W., Chen, T., Ning, Q. and Luo X. (2021) Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients. Frontiers in Endocrinology (Lausanne), 12, Article ID: 596518. https://doi.org/10.3389/fendo.2021.596518
[25]
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H. and Cao, B. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. The Lancet, 395, 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
[26]
Zini, G., Bellesi, S., Ramundo, F. and d’Onofrio, G. (2020) Morphological Anomalies of Circulating Blood Cells in COVID-19. American Journal of Hematology, 95, 870-872. https://doi.org/10.1002/ajh.25824
[27]
Combes, A.J., Courau, T., Kuhn, N.F., Hu, K.H., Ray, A., Chen, W.S., Chew, N.W., Cleary, S.J., Kushnoor, D., Reeder, G.C., et al. (2021) Global Absence and Targeting of Protective Immune States in Severe COVID-19. Nature, 591, 124-130.
https://doi.org/10.1038/s41586-021-03234-7
[28]
Hengeveld, P.J., Khader, A.O., de Bruin, L.H.A., Geelen, I.G.P., van Baalen, E.A., Jansen, E., Bouwer, N.I., Balak, O., Riedl, J.A., Langerak, A.W., Westerweel P.E. and Levin, M.D. (2020) Blood Cell Counts and Lymphocyte Subsets of Patients Admitted during the COVID-19 Pandemic: A Prospective Cohort Study. British Journal of Haematology, 190, e201-e204. https://doi.org/10.1111/bjh.16983
[29]
Kong, M., Zhang, H., Cao, X., Mao, X. and Lu, Z. (2020) Higher Level of Neutrophil-to-Lymphocyte Is Associated with Severe COVID-19. Epidemiology and Infection, 148, e139. https://doi.org/10.1017/S0950268820001557
[30]
Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Deng, Y., Weng, Z. and Yang, L. (2020) Lymphopenia Is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infections: A Systemic Review and Meta-Analysis. International Journal of Infectious Diseases, 96, 131-139. https://doi.org/10.1016/j.ijid.2020.04.086
[31]
Schulte-Schrepping, J., Reusch, N., Paclik, D., Baßler, K., Schlickeiser, S., Zhang, B., Kramer, B., Krammer, T., Brumhard, S., Bonaguro, L., et al. (2020) Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell, 182, 1419-1440.e23. https://doi.org/10.1016/j.cell.2020.08.001
[32]
Kim, J.H., Park, K., Lee, S.B., Kang, S., Park, J.S., Ahn, C.W. and Nam, J.S. (2019) Relationship between Natural Killer Cell Activity and Glucose Control in Patients with Type 2 Diabetes and Prediabetes. Journal of Diabetes Investigation, 10, 1223-1228. https://doi.org/10.1111/jdi.13002
[33]
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y. and Tian, Z. (2020) Functional Exhaustion of Antiviral Lymphocytes in COVID-19 Patients. Cellular & Molecular Immunology, 17, 533-535. https://doi.org/10.1038/s41423-020-0402-2
[34]
Wilk, A.J., Rustagi, A., Zhao, N.Q., Roque, J., Martínez-Colón, G.J., McKechnie, J.L., Ivison, G.T., Ranganath, T., Vergara, R., Hollis, T., Simpsom, L.J., Grant, P., Subramanian, A., Rogers, A.J. and Blish, C.A. (2020) A Single-Cell Atlas of the Peripheral Immune Response in Patients with Severe COVID-19. Nature Medicine, 26, 1070-1076. https://doi.org/10.1038/s41591-020-0944-y
[35]
Wang, F., Nie, J., Wang, H., Zhao, Q., Xiong, Y., Deng, L., Song, S., Ma, Z., Mo, P. and Zhang, Y. (2020) Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. Journal of Infection Diseases, 221, 1762-1769.
https://doi.org/10.1093/infdis/jiaa150
[36]
Leem, G., Cheon, S., Lee, H., Choi, S.J., Jeong, S., Kim, E.S., Jeong, H.W., Jeong, H., Park, S.H., Kim, Y.S. and Shin, E.C. (2021) Abnormality in the NK-Cell Population Is Prolonged in Severe COVID-19 Patients. Journal of Allergy Clinical Immunology, 148, 996-1006.e18. https://doi.org/10.1016/j.jaci.2021.07.022
[37]
Nascimbeni, M., Shin, E.C., Chiriboga, L., Kleiner, D.E. and Rehermann, B. (2004) Peripheral CD4(+)CD8(+) T Cells Are Differentiated Effector Memory Cells with Antiviral Functions. Blood, 104, 478-486.
https://doi.org/10.1182/blood-2003-12-4395
